US FDA approves vaccine to prevent serogroup B Meningococcal disease

Washington: The US Food and Drug Administration on Wednesday announced the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.READ MORE... http://www.indiamedicaltimes.com/2014/10/30/us-fda-approves-vaccine-to-prevent-serogroup-b-meningococcal-disease/